SAFETY OF DAA THERAPY REGARDING RENAL FUNCTION IN POST-LIVER TRANSPLANT PATIENTS INFECTED WITH HEPATITIS C INDEPENDENT OF PRE-EXISTING RENAL IMPAIRMENT, AND A 100% SVR12 RATE - A SINGLE CENTRE STUDY

Georg Peschel  1     Lucia Baier  2     Lukas Moleda  3     Michael Selgrad  1     Marcus Scherer  2     Martina Müller  4     Kilian Weigand    
1 University of Regensburg, Internal Medicine I, Regensburg, Germany
2 University of Regensburg, Surgery, Regensburg, Germany
3 University of Regensburg, Intrenal Medicine I, Regensburg, Germany
4 University of Regens

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing